P26.02 A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results.

Details

Language :

English

ISSN :

15560864

Volume :

16

Issue :

10

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

153097270

Full Text :

https://doi.org/10.1016/j.jtho.2021.08.383